PlainRecalls
FDA Devices Moderate Class II Terminated

LumiraDx SARS-CoV-2 Antibody (Ab) Liquid Quality Control

Reported: July 27, 2022 Initiated: June 24, 2022 #Z-1451-2022

Product Description

LumiraDx SARS-CoV-2 Antibody (Ab) Liquid Quality Control

Reason for Recall

Modification to the LumiraDx SARS-CoV-2 Antibody (Ab) test that was made outside the scope of the approved EUA.

Details

Recalling Firm
LumiraDx
Units Affected
99 units
Distribution
Domestic: AR, CA, FL, MA, MD, NC, NJ, NV, NY, OK, TN, TX, & WI.
Location
Waltham, MA

Frequently Asked Questions

What product was recalled?
LumiraDx SARS-CoV-2 Antibody (Ab) Liquid Quality Control. Recalled by LumiraDx. Units affected: 99 units.
Why was this product recalled?
Modification to the LumiraDx SARS-CoV-2 Antibody (Ab) test that was made outside the scope of the approved EUA.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 27, 2022. Severity: Moderate. Recall number: Z-1451-2022.